ProfTriona Ni Chonghaile

Associate Professor

Physiology and Medical Physics

  • Associate Professor
    Physiology and Medical Physics
  • 4028579 (Work)
  • RCSI, Physiology & Medical Physics, 123 St Stephens Green, Dublin 2

RESEARCH OVERVIEW

Lab Overview: Targeted Therapeutics in Cancer (TTC Lab)

The TTC Lab investigates cell death signalling pathways, with a particular emphasis on the BCL-2 family of proteins that regulate mitochondrial apoptosis. Using advanced techniques such as BH3 profiling, the team measures cellular sensitivity to apoptosis and dependence on anti-apoptotic proteins. This work has been featured in high-impact publications including:

  • Walsh et al., Clinical Cancer Research (2019)
  • Di Grande et al., Blood Advances (2021)
  • Sullivan et al., Science Translational Medicine (2022)
  • Flanagan et al., Hematologica (2024)

 

In a recent breakthrough, the lab identified a novel, specific inhibitor of histone deacetylase 6 (HDAC6) through a screen for compounds that target apoptosis-resistant cancer cells. This discovery unveiled a previously unknown role for HDAC6 in tumour cell metabolism, leading to a US patent application (No. 63/125,759) and publications in:

  • Dowling et al., Science Advances (2021)
  • Roe et al., Nature Communications (2025)
  • Rodrigues et al., Nature communications (2026)

Building on their HDAC6 research, the team has developed a PROTAC-based therapeutic derived from their original small molecule inhibitor. This promising compound holds potential for future clinical development and licensing.

GRANTS

  • FUNDED PROJECT
    Student Selected Projects (SSP) 2027
    RCSI1 Oct 2026 - 30 Sep 2027
  • FUNDED PROJECT
    Precision Oncology Ireland 2.0 (POI2) – WP 2.1A: Modelling childhood cancers from bench to bedside
    Children’s Health Foundation1 Oct 2025 - 30 Sep 2030
  • FUNDED PROJECT
    Precision Oncology Ireland-2 (POI2)
    Research Ireland1 Oct 2025 - 30 Sep 2030
  • FUNDED PROJECT
    Precision Oncology Ireland-2 (POI2)
    Research Ireland1 Oct 2025 - 30 Sep 2030
  • FUNDED PROJECT
    Precision Oncology Ireland-2 (POI2) Doctoral Training Program (DTP)
    Research Ireland1 Oct 2025 - 30 Sep 2030
  • FUNDED PROJECT
    Research Ireland (formerly IRC) 2025 Supplementary Stipend
    Research Ireland1 Jan 2025 - 31 Dec 2025
  • FUNDED PROJECT
    Research Ireland (formerly SFI) 2025 Supplementary Stipend
    Research Ireland1 Jan 2025 - 31 Dec 2025
  • FUNDED PROJECT
    RCSI-Fulbright Joint PhD Programme 2024 Cohort
    RCSI1 Sep 2024 - 30 Sep 2028
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2024
    RCSI29 Apr 2024 - 28 Apr 2025
  • FUNDED PROJECT
    Commercialisation of a Histone deacetylase 6 PROTAC
    Enterprise Ireland25 Mar 2024 - 31 Aug 2024
  • FUNDED PROJECT
    SFI PhD 2024 Additional Stipend Allowance
    Science Foundation Ireland (SFI)1 Jan 2024 - 31 Dec 2024
  • FUNDED PROJECT
    Stipend increase for non state-funded PhD scholars
    RCSI1 Jan 2024 - 30 Sep 2029
  • FUNDED PROJECT
    HEA Support for COVID-19 Related Research Costed Extensions
    Higher Education Authority1 Sep 2023 - 30 Nov 2024
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2023
    RCSI5 Jan 2023 - 30 Sep 2025
  • FUNDED PROJECT
    RCSI International Secondment Awards 2022
    RCSI26 Sep 2022 - 31 Dec 2023
  • FUNDED PROJECT
    Dynamics of ageing and cancer: a multi-functional study into apoptosis, metabolism and the microenvironment - Ageing-MM
    Irish Research Council IRC1 Sep 2022 - 30 Jun 2027
  • FUNDED PROJECT
    Medicinal chemistry approaches to make atypical HDAC6 inhibitors and PROTACs to treat Multiple Myeloma
    RCSI1 Sep 2022 - 31 Aug 2023
  • FUNDED PROJECT
    Medicinal chemistry approaches to make atypical HDAC6 inhibitors and PROTACs to treat Multiple Myeloma
    Irish Research Council IRC1 Sep 2022 - 31 Aug 2023
  • FUNDED PROJECT
    MM_BH3_CutTag
    EU Horizon Europe1 Sep 2022 - 14 Apr 2024
  • FUNDED PROJECT
    Student Selected Projects (SSP) 2022
    RCSI16 May 2022 - 15 May 2023
  • FUNDED PROJECT
    Defining the pro-survival signalling of the bone marrow microenvironment of multiple myeloma
    Irish Cancer Society11 Oct 2021 - 11 Apr 2027
  • FUNDED PROJECT
    StAR International PhD Programme 2021
    RCSI27 Aug 2021 - 30 Sep 2027
  • FUNDED PROJECT
    In depth-characterisation of the role of splenic microenvironment in the development of ABT-199 resistance
    RCSI1 Oct 2020 - 30 Sep 2021
  • FUNDED PROJECT
    In depth-characterisation of the role of splenic microenvironment in the development of ABT-199 resistance
    Irish Research Council IRC1 Oct 2020 - 30 Sep 2021
  • FUNDED PROJECT
    Splen-DID
    Enterprise Ireland H2020 Support18 Sep 2020 - 17 Sep 2021